These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1100948)

  • 81. Autopsy findings in a case of lepromatous leprosy treated with clofazimine.
    Desikan KV; Ramanujam K; Ramu G; Balakrishnan S
    Lepr Rev; 1975 Sep; 46(3):181-9. PubMed ID: 1186410
    [No Abstract]   [Full Text] [Related]  

  • 82. Vitamin A levels of ichthyotic and non-ichthyotic skin and plasma of leprosy patients with and without clofazimine therapy.
    Bharadwaj VP; Sritharan V; Venkatesan K; Girdhar A; Ramu G
    Indian J Med Res; 1982 Jun; 75():773-7. PubMed ID: 7129548
    [No Abstract]   [Full Text] [Related]  

  • 83. [Therapy of leprosy today].
    Bahmer FA; Menzel S
    Hautarzt; 1987 Jan; 38(1):1-3. PubMed ID: 3557977
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Leprosy reactional states and their treatment.
    Jolliffe DS
    Br J Dermatol; 1977 Sep; 97(3):345-52. PubMed ID: 336075
    [No Abstract]   [Full Text] [Related]  

  • 85. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
    Deps P; Guerra P; Nasser S; Simon M
    Lepr Rev; 2012 Sep; 83(3):305-7. PubMed ID: 23356031
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Leprosy and the rheumatoid factor.
    Ellis BP
    Cent Afr J Med; 1978 Jan; 24(1):8-10. PubMed ID: 639105
    [No Abstract]   [Full Text] [Related]  

  • 87. Experience with multidrug therapy in paucibacillary leprosy.
    Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
    Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Diagnosis of leprosy.
    Ye GY
    Int J Dermatol; 1988 May; 27(4):263-4. PubMed ID: 3391720
    [No Abstract]   [Full Text] [Related]  

  • 89. Comments on an editorial by B. R. Chatterjee "On Multi-Drug Combinations in the Treatment of Leprosy".
    Grosset JH; Baohang J; Noordeen SK
    Indian J Lepr; 1989 Jul; 61(3):323-7. PubMed ID: 2768880
    [No Abstract]   [Full Text] [Related]  

  • 90. Clofazimine and the eye: preliminary communication.
    Nêgrel AD; Chovet M; Baquillon G; Lagadec R
    Lepr Rev; 1984 Dec; 55(4):349-52. PubMed ID: 6527599
    [No Abstract]   [Full Text] [Related]  

  • 91. Clofazimine and eosinophilic enteritis.
    Mason GH; Ellis-Pegler RB; Arthur JF
    Lepr Rev; 1977 Sep; 48(3):175-80. PubMed ID: 904424
    [No Abstract]   [Full Text] [Related]  

  • 92. Clofazimine in pregnancy.
    Holdiness MR
    Early Hum Dev; 1989 Feb; 18(4):297-8. PubMed ID: 2702953
    [No Abstract]   [Full Text] [Related]  

  • 93. The influence of leprosy-related clinical and epidemiological variables in the occurrence and severity of COVID-19: A prospective real-world cohort study.
    Cerqueira SRPS; Deps PD; Cunha DV; Bezerra NVF; Barroso DH; Pinheiro ABS; Pillegi GS; Repsold TAR; Kurizky PS; Collin SM; Gomes CM
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009635. PubMed ID: 34319982
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Bacteriological effect of Lamprene (clofazimine) in lepromatous leprosy (report of one year's treatment of 44 patients with 100 mg of Lamprene daily).
    Leiker DL; Blenska W; Carling D; Fitzherbert M; Larssen P
    Lepr Rev; 1971 Jun; 42(2):125-30. PubMed ID: 4948481
    [No Abstract]   [Full Text] [Related]  

  • 95. Image Gallery: Clofazimine-induced hyperpigmentation of leprosy plaques.
    Bishnoi A; Chatterjee D; Narang T; Dogra S
    Br J Dermatol; 2019 Oct; 181(4):e88. PubMed ID: 31281972
    [No Abstract]   [Full Text] [Related]  

  • 96. Tissue levels of clofazimine in a case of leprosy.
    Desikan KV; Balakrishnan S
    Lepr Rev; 1976 Jun; 47(2):107-13. PubMed ID: 948215
    [No Abstract]   [Full Text] [Related]  

  • 97. Management of steroid-dependency with clofazimine (Lamprene or B 663 (Geigy)).
    Morgan J
    Lepr Rev; 1970 Oct; 41(4):229-32. PubMed ID: 5515679
    [No Abstract]   [Full Text] [Related]  

  • 98. A review of side-effects experienced by patients taking clofazimine.
    Moore VJ
    Lepr Rev; 1983 Dec; 54(4):327-35. PubMed ID: 6668986
    [No Abstract]   [Full Text] [Related]  

  • 99. Clofazimine induced pigmentation in leprosy patches.
    Chavhan SD; Jawade S
    Pan Afr Med J; 2022; 42():14. PubMed ID: 35812254
    [No Abstract]   [Full Text] [Related]  

  • 100. The outpatient treatment of nerve damage in patients with borderline leprosy using a semi-standardized steroid regimen.
    Kiran KU; Stanley JN; Pearson JM
    Lepr Rev; 1985 Jun; 56(2):127-34. PubMed ID: 4021699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.